2015
DOI: 10.1016/j.ijantimicag.2015.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
24
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(28 citation statements)
references
References 84 publications
3
24
0
Order By: Relevance
“…Ultimately, both antibiotics functionally and synergistically inhibit the synthesis of folate pathway intermediates, including the essential cofactor THF (Fig. 6), which is why they are used together clinically to treat a wide variety of bacterial infections (15,16). Our results suggest that antibiotics targeting folate biosynthesis affect the expression of Csu pili and that 17978pAB3ϩ resistance to Smx provides protection from the effects of this antibiotic.…”
Section: Resultsmentioning
confidence: 80%
“…Ultimately, both antibiotics functionally and synergistically inhibit the synthesis of folate pathway intermediates, including the essential cofactor THF (Fig. 6), which is why they are used together clinically to treat a wide variety of bacterial infections (15,16). Our results suggest that antibiotics targeting folate biosynthesis affect the expression of Csu pili and that 17978pAB3ϩ resistance to Smx provides protection from the effects of this antibiotic.…”
Section: Resultsmentioning
confidence: 80%
“…Ac . baumannii is an opportunistic pathogen with low virulence which is associated with nosocomial infections and of major concern today because of the emergence of multi-drug resistant isolates 47 . It is unclear why it might be down-regulated in periodontitis relative to health.…”
Section: Resultsmentioning
confidence: 99%
“…Notably, carbapenem resistant Acinetobacter species that were SXT-susceptible were noted. Generally, SXT is not very active against Acinetobacter but it was recommended where there are no other options [20], e.g. for infections with pan-resistant strains or in settings where efficacious drugs like carbapenems are expensive [18].…”
Section: Discussionmentioning
confidence: 99%